Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Globus pallidus calcification, CSF pleocytosis, Thalamic calcification, and Cerebellar calcifications; and common findings: Dysarthria, Antinuclear antibody positivity, Ataxia, and Difficulty with thinking and memory (cognitive impairment) and others. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Seizure, Dysarthria, Ataxia |
CMPK2 encodes cytidine/uridine monophosphate kinase 2 (449 aa). Mitochondrial nucleotide monophosphate kinase needed for salvage dNTP synthesis that mediates immunomodulatory and antiviral activities through IFN-dependent and IFN-independent pathways. Highest expression in Cells EBV-transformed lymphocytes (15.2 TPM) and Lung (6.8 TPM).
Basal ganglia calcification, idiopathic, 10, autosomal recessive is associated with mutations in the CMPK2 gene on chromosome 2.
CMPK2 is classified as a druggable target (Enzyme and Kinase categories) with score 0.0.
Genetic testing for CMPK2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for basal ganglia calcification, idiopathic, 10, autosomal recessive has been reported in the published literature.
Phenotype severity distribution: 4 always present features, 5 common features.
No clinical trials have been registered for basal ganglia calcification, idiopathic, 10, autosomal recessive.
5 publications have been identified in PubMed for basal ganglia calcification, idiopathic, 10, autosomal recessive. Research spans Review / Meta-Analysis (40%), Diagnostic / Biomarker (20%), and Case Report / Case Series (20%).
Yektay Farahmand M (2025). [PMID: 40947452](https://pubmed.ncbi.nlm.nih.gov/40947452/). *J Neurol*. [Review / Meta-Analysis]
Emmi A (2025). [PMID: 39935191](https://pubmed.ncbi.nlm.nih.gov/39935191/). *Ann Clin Transl Neurol*. [Diagnostic / Biomarker]
Monfrini E (2025). [PMID: 41059649](https://pubmed.ncbi.nlm.nih.gov/41059649/). *Mov Disord*. [Basic Science / Preclinical]
Yang D (2025). [PMID: 40456615](https://pubmed.ncbi.nlm.nih.gov/40456615/). *eNeuro*. [Review / Meta-Analysis]
Bonato G (2024). [PMID: 38999439](https://pubmed.ncbi.nlm.nih.gov/38999439/). *J Clin Med*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:37 PM UTC
Online Mendelian Inheritance in Man
Common questions about basal ganglia calcification, idiopathic, 10, autosomal recessive
Lab test results | 2 | Elevated circulating parathyroid hormone level, Antinuclear antibody positivity |
Heart and blood vessels | 1 | Stroke-like episode |